Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

1. NHS screening programmes: duty of candour

NHS screening programmes: duty of candour NHS screening programmes: duty of candour - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Menu Guidance and support Take action now for new rules in 2021 Guidance NHS screening programmes: duty of candour Guidance (...) on applying duty of candour responsibilities and disclosing audit results in NHS screening programmes. Published 13 August 2015 Last updated 5 October 2020 — From: Documents HTML HTML HTML HTML Details This publication provides advice to providers and commissioners of NHS screening programmes on best practice around duty of candour. This relates to being open and transparent in providing information to individuals when they receive a positive diagnosis after a negative screening result

2020 Public Health England

2. ASSIST-Lite screening tool: how to use

ASSIST-Lite screening tool: how to use ASSIST-Lite screening tool: how to use - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Menu Guidance and support Take action now for new rules in 2021 Guidance ASSIST-Lite screening tool: how to use Guidance for health (...) and social care professionals on using the ASSIST-Lite tool to identify substance use and provide appropriate intervention. Published 2 October 2020 From: Documents HTML format This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use

2020 Public Health England

3. NHS population screening: effective text message use

NHS population screening: effective text message use NHS population screening: effective text message use - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Menu Guidance and support Take action now for new rules in 2021 Guidance NHS population screening (...) : effective text message use Principles for the effective use of text messaging in screening and follow-up appointment reminders. Published 28 September 2020 From: Documents HTML HTML Details Public Health England ( to support local screening services to make the most effective use of text message ( Collection Explore the topic Is this page useful? Maybe Yes this page is useful No this page is not useful Thank you for your feedback There is something wrong with this page Close Help us improve GOV.UK Don’t

2020 Public Health England

4. Diabetic eye screening: longer intervals for people at lowest risk

Diabetic eye screening: longer intervals for people at lowest risk Diabetic eye screening: longer intervals for people at lowest risk - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Menu Guidance and support Take action now for new rules in 2021 Guidance (...) Diabetic eye screening: longer intervals for people at lowest risk The gap between routine diabetic eye screening (DES) tests has been extended for those at lowest risk as the NHS restores services safely. Published 23 September 2020 From: Documents Ref: PHE publications gateway number: GW-1577 HTML Details Information for people waiting longer than usual for their routine NHS diabetic eye screening ( with any queries about this publication, making sure you include its full title. Published 23

2020 Public Health England

5. Breast screening: implementing remote image reading

Breast screening: implementing remote image reading Breast screening: implementing remote image reading - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Menu Guidance and support Take action now for new rules in 2021 Guidance Breast screening: implementing (...) remote image reading Guidance for breast screening services undertaking mammogram reading for another service. Published 21 September 2020 Last updated 22 September 2020 — From: Documents Ref: PHE publications gateway number GW-1581 HTML format This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format

2020 Public Health England

6. Screening and Counselling for Alcohol Consumption During Pregnancy

Screening and Counselling for Alcohol Consumption During Pregnancy Guideline No. 405: Screening and Counselling for Alcohol Consumption During Pregnancy - Journal of Obstetrics and Gynaecology Canada Go search , P1158-1173.e1, September 01, 2020 Powered By Mendeley Share on Guideline No. 405: Screening and Counselling for Alcohol Consumption During Pregnancy Lisa Graves Correspondence Corresponding Author: Lisa Graves Affiliations Ancaster, ON George Carson Affiliations Regina, SK Nancy Poole (...) Affiliations Vancouver, BC Tejal Patel Affiliations Hamilton, ON Jodie Bigalky Affiliations Regina, SK Courtney R. Green Affiliations Kingston, ON Jocelynn L. Cook Affiliations DOI: ABSTRACT Objective To establish national standards of care for screening and counselling pregnant women and women of child-bearing age about alcohol consumption and possible alcohol use disorder based on current best evidence. Intended Users Health care providers who care for pregnant women and women of child-bearing age

2020 Society of Obstetricians and Gynaecologists of Canada

7. Multicomponent Interventions to Improve Screening for Breast, Cervical or Colorectal Cancer

Multicomponent Interventions to Improve Screening for Breast, Cervical or Colorectal Cancer Oregon Health Authority : Evidence-based Reports Blog : Health Evidence Review Commission : State of Oregon menu Toggle Main Menu Main Navigation close search Search search Submit You are here: Evidence-based Reports Blog menu Site Navigation Evidence-based Reports Blog Full Width Column 1 Select Ablation for Atrial Fibrillation Acellular Dermal Matrix for Post-Mastectomy Breast Reconstruction Compliance (...) ={ListId}'); return false;} if(pageid == 'audit') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/Reporting.aspx' +'?Category=Auditing&backtype=item&ID={ItemId}&List={ListId}'); return false;} if(pageid == 'config') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/expirationconfig.aspx' +'?ID={ItemId}&List={ListId}'); return false;}}, null); 0x0 0x1 ContentType 0x01 898 BlogTopic Multicomponent Interventions to Improve Screening for Breast, Cervical or Colorectal Cancer

2020 Oregon Health Evidence Review Commission

8. Second and Third Trimester Screening for Fetal Anomaly

Second and Third Trimester Screening for Fetal Anomaly New 2020 ACR Appropriateness Criteria ® 1 Second and Third Trimester Screening for Fetal Anomaly American College of Radiology ACR Appropriateness Criteria ® Second and Third Trimester Screening for Fetal Anomaly Variant 1: Second and third trimester screening for fetal anomaly. Low-risk pregnancy. Initial imaging. Procedure Appropriateness Category Relative Radiation Level US pregnant uterus transabdominal anatomy scan Usually Appropriate (...) O US pregnant uterus transabdominal detailed scan Usually Not Appropriate O US echocardiography fetal Usually Not Appropriate O MRI fetal without and with IV contrast Usually Not Appropriate O MRI fetal without IV contrast Usually Not Appropriate O Variant 2: Second and third trimester screening for fetal anomaly. High-risk pregnancy. Initial imaging. Procedure Appropriateness Category Relative Radiation Level US pregnant uterus transabdominal detailed scan Usually Appropriate O US

2020 American College of Radiology

9. Recommendations for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk

Recommendations for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk 525 University Avenue, 5th Floor, Toronto ON, M5G 2L3 Guidelines for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk Dr. Micheal McInnis, Lead, Radiology Quality Assurance, University Health Network Dr. Heidi Schmidt, Clinical Radiology Lead, Lung Cancer Screening Pilot for People at High Risk Michelle Ang (...) , Lead, Radiology Quality Assurance Program, Cancer Imaging Program Resulting Recommendations Summary Table: Actionable Incidental Findings Recommendations in the context of a high risk lung cancer screening population Incidental Finding Sources Consulted Not Actionable Actionable Indeterminate renal nodule or mass (4) 1. Simple renal cysts (-10 - 20 HU), cysts >70 HU, and nodules too small to characterize. Fatty nodules without calcification (angiomyolipomas) RECOMMENDATION: No further evaluation 1

2020 Cancer Care Ontario

10. Shared follow-up and survivorship care for low-risk endometrial cancer: Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer

Shared follow-up and survivorship care for low-risk endometrial cancer: Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer canceraustralia.gov.au Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer This resource is for all members of the shared care team*. It provides guidance on the screening, assessment and management of supportive care needs of women affected by low-risk endometrial (...) professionals) and the primary care practitioner/s (including General Practitioner (GP) and primary health care nurse).Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer canceraustralia.gov.au © Cancer Australia 2020 SCSAE08/20 Screening, assessing and managing the effects of treatment, co-morbidities and secondary prevention are important aspects of a holistic and multidisciplinary approach to managing follow-up care for women with low-risk endometrial

2020 Cancer Australia

11. Performance of (18)F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis

Performance of (18)F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis Performance of 18 F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis - PubMed This site needs JavaScript to work properly. Please (...) options Display options Format Share Permalink Copy Page navigation Thromb Res Actions . 2020 Jun 23;194:153-157. doi: 10.1016/j.thromres.2020.06.034. Online ahead of print. Performance of 18 F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis , , , , , , , Affiliations Expand Affiliations 1 Service de Médecine Nucléaire, EA 3878 (GETBO), Centre Hospitalier

2020 EvidenceUpdates

12. Identifying Features of Screening Approaches for People at Increased Risk of Colorectal Cancer

Identifying Features of Screening Approaches for People at Increased Risk of Colorectal Cancer Rapid Synthesis Identifying Features of Screening Approaches for People at Increased Risk for Colorectal Cancer 31 August 2020 McMaster Health Forum 1 Evidence >> Insight >> Action Rapid Synthesis: Identifying Features of Screening Approaches for People at Increased Risk of Colorectal Cancer 30-day response 31 August 2020 Identifying Features of Screening Approaches for People at Increased Risk (...) scientific rigour and system relevance. Acknowledgments The authors wish to thank David Armstrong and Paul James for their insightful comments and suggestions. Citation Bhuiya AR, Scallan E, Sharma K, Wilson MG. Rapid synthesis: Identifying features of screening approaches for people at increased risk of colorectal cancer. Hamilton, Canada: McMaster Health Forum, 31 August 2020. Product registration numbers ISSN 2292-7999 (online)McMaster Health Forum 3 Evidence >> Insight >> Action KEY MESSAGES

2020 McMaster Health Forum

13. Breast screening: very high risk women surveillance protocols

Breast screening: very high risk women surveillance protocols Breast screening: higher risk women surveillance protocols - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Breast screening: higher risk women surveillance protocols The NHS breast surveillance protocols for women at higher risk of developing breast cancer. Published 1 June 2013 Last updated 8 July 2019 — From: Documents If you use assistive (...) technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. format This file may not be suitable for users of assistive technology. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive

2020 Public Health England

14. NHS population screening: a health equity audit guide

NHS population screening: a health equity audit guide NHS population screening: a health equity audit guide - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance NHS population screening: a health equity audit guide Guidance for screening providers

2020 Public Health England

15. Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial. (Full text)

Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial. To investigate whether opportunistic screening in primary care increases the detection of atrial fibrillation compared with usual care.Cluster randomised controlled trial.47 intention-to-screen and 49 usual care primary care practices in the Netherlands, not blinded for allocation; the study was carried out from September 2015 to August 2018.In each practice (...) , a fixed sample of 200 eligible patients, aged 65 or older, with no known history of atrial fibrillation in the electronic medical record system, were randomly selected. In the intention-to-screen group, 9218 patients eligible for screening were included, 55.0% women, mean age 75.2 years. In the usual care group, 9526 patients were eligible for screening, 54.3% women, mean age 75.0 years.Opportunistic screening (that is, screening in patients visiting their general practice) consisted of three index

2020 BMJ PubMed abstract

16. Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis : An Individual Participant-Based Meta-analysis. (Abstract)

Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis : An Individual Participant-Based Meta-analysis. Although measuring albuminuria is the preferred method for defining and staging chronic kidney disease (CKD), total urine protein or dipstick protein is often measured instead.To develop equations for converting urine protein-creatinine ratio (PCR) and dipstick protein to urine albumin (...) -creatinine ratio (ACR) and to test their diagnostic accuracy in CKD screening and staging.Individual participant-based meta-analysis.12 research and 21 clinical cohorts.919 383 adults with same-day measures of ACR and PCR or dipstick protein.Equations to convert urine PCR and dipstick protein to ACR were developed and tested for purposes of CKD screening (ACR ≥30 mg/g) and staging (stage A2: ACR of 30 to 299 mg/g; stage A3: ACR ≥300 mg/g).Median ACR was 14 mg/g (25th to 75th percentile of cohorts, 5

2020 Annals of Internal Medicine

17. Universal screening for SARS?CoV?2 infection: a rapid review

Universal screening for SARS?CoV?2 infection: a rapid review Universal screening for SARS‐CoV‐2 infection: a rapid review - Viswanathan, M - 2020 | Cochrane Library Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in . Trusted evidence. Informed decisions. Better health (...) Banner Portlet Scolaris Content Display Scolaris Content Display Read comments on this Review(0) Cochrane Clinical Answers Editorials Podcasts Special Collections Universal screening for SARS‐CoV‐2 infection: a rapid review Cochrane Systematic Review - Rapid Version published: 15 September 2020 Collapse all Expand all Abstract available in Background Coronavirus disease 2019 (COVID‐19) is caused by the novel betacoronavirus, severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Most people

2020 Cochrane

18. SMFM Special Statement: Checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin

SMFM Special Statement: Checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin Society for Maternal-Fetal Medicine Special Statement: Checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin - American Journal of Obstetrics & Gynecology Go search , PB7-B11, September 01, 2020 Powered By Mendeley Share on Society for Maternal-Fetal Medicine Special Statement: Checklists for preeclampsia risk (...) -factor screening to guide recommendations for prophylactic low-dose aspirin SMFM Patient Safety and Quality Committee ∗ C. Andrew Combs Affiliations Patient Safety and Quality Improvement Committee, Society for Maternal-Fetal Medicine, Washington, DC Douglas M. Montgomery Affiliations Patient Safety and Quality Improvement Committee, Society for Maternal-Fetal Medicine, Washington, DC Published: June 14, 2020 DOI: In pregnant individuals with risk factors for preeclampsia, prophylactic low-dose

2020 Society for Maternal-Fetal Medicine

19. Breast screening: organising very high risk (VHR) screening

Breast screening: organising very high risk (VHR) screening Breast screening: organising very high risk (VHR) screening - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Breast screening: organising very high risk (VHR) screening Information for breast (...) screening service staff about how to organise very high risk (VHR) screening as part of the NHS Breast Screening Programme (NHS BSP). Published 1 March 2013 Last updated 8 September 2020 — From: Documents Ref: PHE publications gateway number GW-1546 HTML Details Every screening service is expected to have arrangements in place for managing women in their area who are eligible for All the with any queries about this publication, making sure you include its full title. Published 1 March 2013 Last updated

2020 Public Health England

20. Diabetic eye screening programme: failsafe procedures

Diabetic eye screening programme: failsafe procedures Diabetic eye screening programme: failsafe procedures - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Diabetic eye screening programme: failsafe procedures These documents set out how the failsafe (...) processes work for the NHS diabetic eye screening (DES) programme. Published 1 January 2013 Last updated 4 September 2020 — From: Documents . Please tell us what format you need. It will help us if you say what assistive technology you use. Ref: PHE gateway number 2018613 HTML Details Failsafe processes minimise risks of anything going wrong in the screening pathway. These publications explain the failsafe procedures in place for the diabetic eye screening programme. Published 1 January 2013 Last

2020 Public Health England